abstract |
The present invention provides compositions and methods useful for the modulation of signaling through the Toll-like receptor TLR7 and / or TLR8. The compositions and methods are used to treat autoimmune, inflammatory allergies, asthma, graft rejection, graft versus host disease, infection, sepsis, cancer and immunodeficiency. |